Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
NCT06293898
This study is recruiting at 24 US sites in 13 states, according to its ClinicalTrials.gov record last updated .
Summary
The objective of this study is to evaluate the safety, tolerability, and efficacy of BL-M07D1 in patients with HER2 expressing advanced tumors.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Endometrial Cancer
- Cervical Cancer
- Ovarian Cancer
- Urothelial Carcinoma
- Biliary Tract Cancer
- Breast Cancer
- Lung Cancer
- Gastric Cancer
- Gastroesophageal-junction Cancer
- Esophageal Cancer
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 1
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- SystImmune Inc.
- Last updated on ClinicalTrials.gov
- October 13, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Alabama · 1
- University of Alabama Birmingham · Birmingham, AL
California · 4
- City of Hope · Duarte, CA
- Cedars Sinai · Los Angeles, CA
- START - Los Angeles · Los Angeles, CA
- Scripps Health · San Diego, CA
Florida · 2
- University of Miami · Miami, FL
- Sarah Cannon Research Institute - Lake Nona Florida · Orlando, FL
Georgia · 1
- Georgia Cancer Center at Augusta University · Augusta, GA
Illinois · 3
- University of Chicago Medicine · Chicago, IL
- University of Illinois Cancer Center · Chicago, IL
- City of Hope - Chicago · Zion, IL
Massachusetts · 1
- Dana Farber Cancer Institute · Boston, MA
Michigan · 1
- Karmanos Cancer Institiute · Detroit, MI
New Jersey · 1
- START - New Jersey · East Brunswick, NJ
New York · 3
- Start (Nyli) · Lake Success, NY
- NYU Langone Hospital - Long Island Investigational Pharmacy · Mineola, NY
- Laura & Isaac Perlmutter Cancer Center at NYU Langone Health · New York, NY
Oregon · 2
- Providence Cancer Institute (Westside) · Portland, OR
- Providence Portland Medical Center · Portland, OR
Tennessee · 1
- Sarah Cannon Research Institute · Nashville, TN
Texas · 3
- Start - Dfw · Fort Worth, TX
- Oncology Consultants · Houston, TX
- START - San Antonio · San Antonio, TX
Virginia · 1
- Virginia Cancer Specialists · Fairfax, VA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.